| Filed On | Filing |
|---|---|
| 12 Feb 2026 |
Form 4/A: Rau Diogo, EVP & CIDO
Received 4,599.164 shares as a grant or award ($4.8M) |
| 28 Oct 2020 |
Form 4/A: Barnes Melissa S, Chief Eth/Cmpl Ofcr & SVP, ERM
Sold 5,000 shares ($755K) |
| 09 Jan 2020 |
Form 4/A: O'Neill Myles, SVP & Pres., Mfg. Operations
Holds 33,469 shares of Common Stock |
| 20 Nov 2019 |
Form 4/A: Walker Karen, Director
Received 92 shares as a grant or award ($9.93K) |
| 09 Sep 2019 |
Form 4/A: Zulueta Alfonso G, SVP & President, Lilly Int'l
Sold 19,500 shares ($2.2M) |
| 16 May 2019 |
Form 4/A: Shaw Christi, SVP and Pres., Lilly Bio-Meds
Sold 7,077 shares ($829K) |
| 20 Feb 2019 |
Form 4/A: Zakrowski Donald A, Chief Accounting Officer
Received 3,245 shares as a grant or award ($390K) |
| 20 Feb 2019 |
Form 4/A: Shah Aarti S., SVP & CIO
Received 5,940 shares as a grant or award ($714K) |
| 20 Feb 2019 |
Form 4/A: Norton Johna, Senior VP, Global Quality
Received 2,960 shares as a grant or award ($356K) |
| 20 Feb 2019 |
Form 4/A: Fry Stephen F, SVP, HR & Diversity
Received 19,405 shares as a grant or award ($2.33M) |
| 20 Feb 2019 |
Form 4/A: Conterno Enrique A, SVP&Pres, LillyDiab & LillyUSA
Received 26,682 shares as a grant or award ($3.21M) |
| 20 Feb 2019 |
Form 4/A: Harrington Michael J, Senior VP and General Counsel
Received 28,156 shares as a grant or award ($3.38M) |
| 20 Feb 2019 |
Form 4/A: Smiley Joshua L, SVP and CFO
Received 9,955 shares as a grant or award ($1.2M) |
| 20 Feb 2019 |
Form 4/A: O'Neill Myles, SVP & Pres., Mfg. Operations
Received 13,283 shares as a grant or award ($1.6M) |
| 06 Feb 2019 |
Form 4/A: Lilly Eli & Co, Less than 10% Owner · Zymeworks BC Inc.
Holds 1,827,101 shares of Common Stock |
| 01 Feb 2019 |
Form 4/A: Tai Jackson P, Director
Bought 1,568 shares ($149K) |
| 01 Feb 2019 |
Form 4/A: O'Neill Myles, SVP & Pres., Mfg. Operations
Holds 32,053 shares of Common Stock |
| 01 Feb 2019 |
Form 4/A: Mahony Susan, SVP & Pres., Lilly Oncology
Sold 17,379 shares ($1.39M) |
| 27 Jul 2018 |
Form 4/A: Tai Jackson P, Director
Bought 2,168 shares ($206K) |
| 01 Jun 2018 |
Form 4/A: Shaw Christi, SVP and Pres., Lilly Bio-Meds
Sold 8,426 shares ($692K) |
Loading...
